Concepedia
Statistics
Publications
33
Citations
977
H-Index
19
Active since
1992
Affiliations
The University of Tokyo(Current)
Pfizer (Japan)
Mochida Pharmaceutical (Japan)
Pfizer (United States)
NTT Medical Center
Kazunari Nakao is an author at The University of Tokyo specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryPharmacotherapyNatural SciencesMedicinal ChemistryImmunologyDrug DevelopmentOrganic Chemistry
Publications per year
1992–2017
CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties
Kazunari Nakao, Akio Murase, Hiroyuki Ohshiro et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 120 citations
Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase
Takashi Mano, Rodney W. Stevens, Kazuo Ando et al. · Bioorganic & Medicinal Chemistry · 2003 · 57 citations
Novel Imidazole Compounds, Medicinal Chemistry, Biochemistry +11
Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation
Akio Murase, Takako Okumura, Ayano Sakakibara et al. · European Journal of Pharmacology · 2007 · 56 citations
Inflammation, Anti-inflammatory, Health Sciences +10
Efficient Synthesis of [6-Chloro-2-(4-chlorobenzoyl)-1<i>H</i>-indol-3-yl]-acetic Acid, a Novel COX-2 Inhibitor
Stéphane Caron, Enrique Vázquez, Rodney W. Stevens et al. · The Journal of Organic Chemistry · 2003 · 56 citations
Medicinal Chemistry, Novel Cox-2 Inhibitor, Bioorganic Chemistry +13
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist
Akio Murase, Yasuhito Taniguchi, Hiroko Tonai‐Kachi et al. · Life Sciences · 2007 · 48 citations
Molecular Pharmacology, Medicine, Immunology +7
Rows per page
1–5 of 33